These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8674871)

  • 21. [Medical treatment of arteriosclerosis obliterans (ASO)].
    Matsuo H
    Nihon Geka Gakkai Zasshi; 1996 Jul; 97(7):520-5. PubMed ID: 8808815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of low-density lipoprotein apheresis in arteriosclerosis obliterans of the lower extremities: two cases with marked alleviation of clinical symptoms.
    Suzuki T; Sato Y; Niizuma S; Kushiro T; Tani S; Ishikawa K; Kajiwara N; Kanmatsuse K; Ikeda H; Takahashi M; Kojima S
    J Clin Apher; 2007; 22(5):287-91. PubMed ID: 17610290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Use of drug-free methods of treatment in comprehensive therapy of patients with stage II chronic lower limb ischaemia].
    Makarov IV; Lukashova AV
    Angiol Sosud Khir; 2016; 22(2):21-6. PubMed ID: 27336329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Occlusive peripheral arterial disease. Guidelines for office management.
    Spittell JA
    Postgrad Med; 1982 Feb; 71(2):137-42, 146, 150-1. PubMed ID: 6460230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Walking training for intermittent claudication in diabetes.
    Ubels FL; Links TP; Sluiter WJ; Reitsma WD; Smit AJ
    Diabetes Care; 1999 Feb; 22(2):198-201. PubMed ID: 10333933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of diabetes on the prognosis, serum inflammatory factors, and quality of life of patients with lower extremity arteriosclerosis obliterans after vascular intervention: a retrospective comparative cohort study.
    Zhao H; Zhuo T; Hao X; Fan X; Zhao P
    Ann Palliat Med; 2022 Aug; 11(8):2720-2729. PubMed ID: 36064362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Analysis of clinical state for arteriosclerosis obliterans in lower extremity of diabetic patients on peritoneal dialysis].
    Shi JB; Sun QH; Nie JD; Sun LH; Zhang N; Han QF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Feb; 45(1):109-13. PubMed ID: 23411531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for development of critical limb ischemia -- a survey of diabetic vs. nondiabetic population.
    Bosevski M; Meskovska S; Tosev S; Peovska I; Asikov I; Georgievska-Ismail LJ
    Prilozi; 2006 Dec; 27(2):89-96. PubMed ID: 17211294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Analysis of peripheral arterial obstructive disease related factors among diabetic population aged > or = 50].
    Guan H; Liu ZM; Li GW; Guo XH; Xu ZR; Zou DJ; Xing HL; Liu W; Sheng ZY; Tian HM; Zhu DL; Yu DM; Zhuang WT; Chen LL; Weng JP
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(1):23-7. PubMed ID: 17403307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Principle of treatment of intermittent claudication due to arteriosclerosis obliterans--reconstruction or conservative treatment].
    Hachiya T; Kaneko H; Shiraishi A; Unno N; Baba S; Sakaguchi S; Koyano K
    Nihon Geka Gakkai Zasshi; 1992 Sep; 93(9):1040-2. PubMed ID: 1470112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of LDL apheresis and vitamin E-modified membrane on carotid atherosclerosis in hemodialyzed patients with arteriosclerosis obliterans.
    Nakamura T; Kawagoe Y; Matsuda T; Takahashi Y; Sekizuka K; Ebihara I; Koide H
    Kidney Blood Press Res; 2003; 26(3):185-91. PubMed ID: 12886046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and feasibility of dobutamine-atropine stress echocardiography for the diagnosis of coronary artery disease in diabetic patients unable to perform an exercise stress test.
    Elhendy A; van Domburg RT; Poldermans D; Bax JJ; Nierop PR; Geleijnse ML; Roelandt JR
    Diabetes Care; 1998 Nov; 21(11):1797-802. PubMed ID: 9802723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative and qualitative derangement of apolipoprotein B-containing lipoproteins as a risk factor for diabetic macroangiopathy in nonobese NIDDM subjects.
    Harano Y; Kageyama A; Nakao Y; Hara Y; Suzuki M; Sato A; Ikebuchi M; Shinozaki K; Tsushima M
    Diabetes; 1996 Jul; 45 Suppl 3():S31-4. PubMed ID: 8674886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exercise after heparin administration: new therapeutic program for patients with-option arteriosclerosis oblitrans.
    Maejima Y; Yasu T; Ueba H; Kobayashi N; Hashimoto S; Kubo N; Kakehashi A; Isobe M; Kawakami M; Saito M
    Circ J; 2005 Sep; 69(9):1099-104. PubMed ID: 16127194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atherosclerosis obliterans of the lower extremities in Thai patients.
    Mutirangura P; Ruangsetakit C; Wongwanit C; Sermsathanasawadi N; Chinsakchai K
    J Med Assoc Thai; 2006 Oct; 89(10):1612-20. PubMed ID: 17128835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between Angiotensin II, Vascular Endothelial Growth Factor, and Arteriosclerosis Obliterans.
    Liu Y; Cui Y; Zhou Z; Liu B; Liu Z; Li G
    Dis Markers; 2023; 2023():1316821. PubMed ID: 36865500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin resistance and arteriosclerosis obliterans in patients with NIDDM.
    Matsumoto K; Miyake S; Yano M; Ueki Y; Yamaguchi Y; Akazawa S; Tominaga Y
    Diabetes Care; 1997 Nov; 20(11):1738-43. PubMed ID: 9353618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pathophysiology and diagnosis for arteriosclerosis obliterans].
    Sasaki H; Konisi K
    Rinsho Byori; 2002 Aug; 50(8):802-6. PubMed ID: 12373817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Comparison of Clinical Outcomes for Diabetic and Nondiabetic Patients Following Directional Atherectomy in the DEFINITIVE LE Claudicant Cohort.
    Garcia LA; Jaff MR; Rocha-Singh KJ; Zeller T; Bosarge C; Kamat S; McKinsey JF
    J Endovasc Ther; 2015 Oct; 22(5):701-11. PubMed ID: 26250748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-density lipoprotein apheresis in a patient with arteriosclerosis obliterans and light chain deposition disease.
    Nakamura T; Kawagoe Y; Matsuda T; Ueda Y; Koide H
    Clin Nephrol; 2004 Jun; 61(6):429-33. PubMed ID: 15224807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.